FDA 483 - ANI Pharmaceuticals Inc - December 06, 2024

The provided document content was unavailable for review. Therefore, a summary cannot be generated as it requires access to the full text of the FDA 483 document to identify the company name, inspection dates, main violations, regulatory framework, and required actions. Please provide the complete document for a comprehensive summary.